<unk>  is a transthyretin-directed small interfering RNA that is FDA approved for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults.   Common adverse reactions include upper respiratory tract infections and infusion-related reactions.
Patisiran
Lenograstim
Bepridil
Zileuton
Cetiedil
Atopaxar
Fasudil
Belinostat